コンテンツへスキップ
Merck

BPS78000

ADAM17 Fluorogenic Assay Kit

別名:

Assay Kits, Alpha, Disintegrin And Metalloproteinase Domain-Containing Protein, Tumor Necrosis Factor

ログインで組織・契約価格をご覧ください。

サイズを選択してください

表示を変更する

この商品について

UNSPSC Code:
41105331
テクニカルサービス
お困りのことがあれば、経験豊富なテクニカルサービスチームがお客様をサポートします。
お手伝いします


manufacturer/tradename

BPS Bioscience

technique(s)

activity assay: suitable (Fluorogenic)

UniProt accession no.

shipped in

dry ice

storage temp.

-65 to -96°C

General description

The ADAM17 Fluorescent Assay Kit is provided in a convenient 96-well format, with purified ADAM17, ADAM Fluorogenic Substrate, and ADAM assay buffer for 96 enzyme reactions. The key to the ADAM17 Fluorescent Assay Kit is the fluorogenic substrate. Using this kit, only one simple step on a microtiter plate is required for ADAM17 reactions. A sample containing ADAM17 is incubated in a reaction mixture with the fluorogenic substrate and fluorescence (λex=485±10 nm, λem=530±10 nm) is measured using a plate reader.

Application

Study enzyme kinetics and screen small molecule inhibitors of ADAM17 for drug discovery and high throughput screening (HTS) applications.
ADAM17 (A disintegrin and a metalloprotease 17), also known as TACE (TNF-α converting enzyme), is one of the 22 members of the ADAM family of proteins found in humans and part of the zinc protease superfamily. It is involved in development, immunity, inflammation and tumorigenesis. ADAM17 is found in the brain, heart, kidney and skeletal muscle, amongst others. It has more than 80 substrates, ranging from EGFR (epidermal growth factor receptor) ligands, TNF-α (tumor necrosis factor alpha) to adhesion molecules and amyloid precursor protein, and it is thus involved in multiple pathways. Its activity is highly regulated, with low activity resulting in issues with regeneration due to low EFGR signaling, while increased activity can lead to tumor development. This protein is formed in the ER (endoplasmic reticulum) as a proform and matures in the Golgi apparatus where the prodomain is cleaved by pro-protein convertases. Patients with RA (rheumatoid arthritis) have elevated activity of ADAM17 in the synovial tissue. Because of the roles it plays, targeting this protein in diseased tissues without affecting the healthy tissues is a major concern. The development of therapies targeting this protein in specific tissues will no doubt result in advances in ADAM-17 related diseases.
Datasheet and Protocols may be found here.


ハザードコード

注意事項

Hazard Classifications

Aquatic Chronic 3

保管分類

10 - Combustible liquids

一体何が起きているの?

WGK 3


適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

Please refer to KIT Component information

pdsc

Please refer to KIT Component information

prtr

Please refer to KIT Component information

fsl

Please refer to KIT Component information

ishl_indicated

Please refer to KIT Component information

ishl_notified

Please refer to KIT Component information

cart

キットコンポーネントの情報を参照してください

jan



最新バージョンのいずれかを選択してください:

試験成績書(COA)

Lot/Batch Number

適切なバージョンが見つかりませんか。

特定のバージョンが必要な場合は、ロット番号またはバッチ番号で特定の証明書を検索できます。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする